Baicalein self‐microemulsion based on drug-phospholipid complex for the alleviation of cytokine storm

Abstract Cytokine storm is a phenomenon whereby the overreaction of the human immune system leads to the release of inflammatory cytokines, which can lead to multiple organ dysfunction syndrome. At present, the existing drugs for the treatment of cytokine storm have limited efficacy and severe adver...

Full description

Saved in:
Bibliographic Details
Main Authors: Hengfeng Liao (Author), Jun Ye (Author), Yue Gao (Author), Chunfang Lian (Author), Lu Liu (Author), Xiaoyan Xu (Author), Yu Feng (Author), Yanfang Yang (Author), Yuqi Yang (Author), Qiqi Shen (Author), Lili Gao (Author), Zhihua Liu (Author), Yuling Liu (Author)
Format: Book
Published: Wiley, 2023-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_1d6aa59bba2d4a5ca0c1f3f926c428f7
042 |a dc 
100 1 0 |a Hengfeng Liao  |e author 
700 1 0 |a Jun Ye  |e author 
700 1 0 |a Yue Gao  |e author 
700 1 0 |a Chunfang Lian  |e author 
700 1 0 |a Lu Liu  |e author 
700 1 0 |a Xiaoyan Xu  |e author 
700 1 0 |a Yu Feng  |e author 
700 1 0 |a Yanfang Yang  |e author 
700 1 0 |a Yuqi Yang  |e author 
700 1 0 |a Qiqi Shen  |e author 
700 1 0 |a Lili Gao  |e author 
700 1 0 |a Zhihua Liu  |e author 
700 1 0 |a Yuling Liu  |e author 
245 0 0 |a Baicalein self‐microemulsion based on drug-phospholipid complex for the alleviation of cytokine storm 
260 |b Wiley,   |c 2023-01-01T00:00:00Z. 
500 |a 2380-6761 
500 |a 10.1002/btm2.10357 
520 |a Abstract Cytokine storm is a phenomenon whereby the overreaction of the human immune system leads to the release of inflammatory cytokines, which can lead to multiple organ dysfunction syndrome. At present, the existing drugs for the treatment of cytokine storm have limited efficacy and severe adverse effects. Here, we report a lymphatic targeting self‐microemulsifying drug delivery system containing baicalein to effectively inhibit cytokine storm. Baicalein self‐microemulsion with phospholipid complex as an intermediate carrier (BAPC‐SME) prepared in this study could be spontaneously emulsified to form 12‐nm oil‐in‐water nanoemulsion after administration. And then BAPC‐SME underwent uptake by enterocyte through endocytosis mediated by lipid valve and clathrin, and had obvious characteristics of mesenteric lymph node targeting distribution. Oral administration of BAPC‐SME could significantly inhibit the increase in plasma levels of 14 cytokines: TNF‐α, IL‐6, IFN‐γ, MCP‐1, IL‐17A, IL‐27, IL‐1α, GM‐CSF, MIG, IFN‐β, IL‐12, MIP‐3α, IL‐23, and RANTES in mice experiencing systemic cytokine storm. BAPC‐SME could also significantly improve the pathological injury and inflammatory cell infiltration of lung tissue in mice experiencing local cytokine storm. This study does not only provide a new lymphatic targeted drug delivery strategy for the treatment of cytokine storm but also has great practical significance for the clinical development of baicalein self‐microemulsion therapies for cytokine storm. 
546 |a EN 
690 |a baicalein 
690 |a cytokine storm 
690 |a lymphatic transport 
690 |a phospholipid complex 
690 |a SMEDDS 
690 |a Chemical engineering 
690 |a TP155-156 
690 |a Biotechnology 
690 |a TP248.13-248.65 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Bioengineering & Translational Medicine, Vol 8, Iss 1, Pp n/a-n/a (2023) 
787 0 |n https://doi.org/10.1002/btm2.10357 
787 0 |n https://doaj.org/toc/2380-6761 
856 4 1 |u https://doaj.org/article/1d6aa59bba2d4a5ca0c1f3f926c428f7  |z Connect to this object online.